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Inhaled cromoglycate versus nedocromil:
clinical results
L. Armenio, L. Brunetti,. D. Colazzo and F. Cardinale
Istituto di Pediatria Clinica e Sociale, Universit
di Bari, Policlinico, Piazza G. Cesare, 1-70124
Bari, Italy
Recent national and international protocols recommend
the use of anti-inflammatory agents for the long-term
treatment of asthma both in children and in adults. Because
of their biologically demonstrated anti-inflammatory prop-
erties, and their efficacy and safety in the clinical setting,
sodium cromoglycate and nedocromil sodium are among
the first-line drugs used as alternatives to, or in association
with, topically applied steroids. Although some experi-
mental and clinical evidence seems to indicate that
nedocromil is more effective than sodium cromoglycate in
treating asthma, the issue is still open. In an attempt to
contribute to the debate, the results of clinical studies that
have been performed with these two cromones have been
reviewed.
Anti-inflammatory therapy with nedocromil in
chronic bronchopneumopathy (asthma and
cystic fibrosis)
G. Caramia, F. Franceschini and R. Gagliardini
Paediatric-Neonatology Division, G. Salesi Hospital, Via
Corridoni 11, 1-60123 Ancona, Italy
Preliminary results of two parallel and complementary
studies whose aim is to evaluate the efficacy of long-term
therapy with inhaled nedocromil (Nc) in patients affected
with mild-moderate asthma and with cystic fibrosis (CF)
are reported. Before and after 2 months of therapy with
NC, 16 patients (ten with asthma and six with CF) were
examined and evaluated through clinical data, fundamen-
tal spirometric parameters (FVC, FEv1, FEF25-75), and
bronchial hyper-reactivity (BHR). The results obtained
confirm the efficacy of NC in improving spirometric data
and BHR in asthmatic patients. Using the same parameters,
the therapeutic benefits of NC in children with CF ap-
peared less evident, this is probably due to the numerous
factors that can influence bronchial inflammation in CF.
Reduced priming capacity of bronchoalveolar
lavage liquid on polymorphonuclear
leukocytes after nedocromil sodium therapy
in asthtnatic children
R. Gabbianelli, A. Kantar, N. Oggiano, M. Gentili,3
R. Pagni, G. Falcioni and P. L. Giorgi
1Department of Biology M.C.A., University of Camerino,
Via Camerini, 2, 62032 Camerino, Italy; 2Department of
Paediatrics, University of Ancona, Ancona, Italy;
Intensive Care Unit, Children’s Hospital, Ancona, Italy
A variety of inflammatory cell types and mediators of
inflammation have been noted in the broncoalveolar
lavage (BAL) of asthmatic patients. These components
exhibit a priming on phagocytic cells. The priming effect
of BAL on polymorphonuclear leukocytes (PMNs) was
studied in asthmatic children before and after nedocromil
therapy, using a chemiluminescence technique. Our data
demonstrate a significant reduction in the priming activity
of BAt, after nedocromil sodium therapy. This effect Can be
partially attributed to the action of nedocromil on inflam-
matory cells and on the release of mediators.
(C) 1994 Rapid Communications of Oxford Ltd
Effect of inhaled nedocromil sodium therapy
on blood gas changes in asthmatic children
challenged with ultrasonically nebulized
distiIled water: a comparison of 8 mg versus
16 mg daily dose
N. Oggiano, A. Kantar, S. Bruni, F. M. Cutrona,
E. Fabbrizi, R. Piccinini and P. L. Giorgi
Department of Paediatrics, University of Ancona, Via
Corridoni 11, 1-60123 Ancona, Italy
Changes in the time courses of blood partial pressures of
oxygen (Pt%) and carbon dioxide (Ptco2) before, during
and after challenge with ultrasonically nebulized distilled
water (UNDW) were evaluated in 22 children with mild
asthma in basal conditions, and after 8 weeks of therapy
with inhaled nedocromil sodium at a daily dosage of 8 or
16 mg. Pto and Ptco were followed, using a
transcutaneous % and co monitoring system. All asthmatic
subjects presented a significant decrease in Pt% and/or
Ptco (>20% basal value) during or after challenge. After
therapy, the decrease in Pto and Ptc% was normalized in
the group treated with 16 mg/day, whereas only a partial
yet significant reduction in the decrease of o,. and co was
observed in the group assuming 8 mg/day. These data
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indicate that inhaled nedocromil is effective in treating
bronchial hyper-responsiveness in childhood, and that the
dose required to achieve this effect is 16 mg/day.
The effects of SCG and ipratropium bromide
on two bronchial challenges (hyperosmolar
solution and exercise)
M. Miraglia del Giudice, Jr, F. Decimo, C. Capristo,
L. Masini and N. Maiello
and IV Paediatric Clinic, II University of Naples,
Naples, Italy
conclusion of which a bronchial provocation test with
methacoline was also carried out). Clinical and drug-use
scores, comparable at the beginning of the physical exer-
cise in both groups, showed a statistical difference at the
end of the study in the swimming group (p < 0.05). Only
one swimmer (10%) had a positive methacoline result,
compared with three footballers (43%). Comparing the
drug-related scores, statistical significance only resulted for
sodium cromoglycate (p < 0.05). In the absence of a pure
study comparing two drug-free populations, it is difficult to
say whether improvement in the swimmers is due to this
sport or to the effects of cromoglycate.
To understand how exercise induced asthma (EIA) may be
related to changes in airway osmolarity, a study was made
of the inhibitory effects of two drugs, ipratropium bromide
and SCG on two bronchial challenges; namely
hyperosmolar solution (HY) and exercise (EX), in 15 asth-
matic children. The children were screened by EX and HY
tests at the beginning and after pretreatment (double-
blind) with either placebo, or 10 mg SCG, or 80 mg
ipratropium bromide. Both drugs were able to inhibit the
challenge with HY and EX in almost all the patients.
However, because the protection against HY was more
significant than against EX, our data suggest that
hyperosmolarity may not be the only mechanism involved
in EIA.
Clinical-epidemiological evaluation of the use
of disodiumcromoglycate from 1980 to 1992
G. L. Grzincich, G. Pisi, M. E. Street, A. Pelizzoni and
A. Battistini
Centro di Fisiopatologia Respiratoria Infantile, and
Clinica Pediatrica, Universitt di Parma Via Gramsci 14,
43100, Parma, Italy
The examination of data from 1925 asthmatic patients
(9 months-18 years) pointed to a significant increase in the
use of beta-2-stimulators, ketotifen and nedocromil sodium
from 1980 to 1992; on the other hand, the use of
disodiumcromoglycate (DSCG) and of theophilline was
unchanged. General physicians prescribe DSCG princi-
pally in allergic patients, or if they have made a diagnosis
of asthma. Of the three formulations of DSCG, phials are
used in the younger children, capsules and spray in the
older ones and in allergic subjects. DSCG in our study was
taken correctly in 57% of the cases.
Asthma and sport: efficacy of a kind of sport,
or a kind of therapy?
M. Canciani
Children’s Hospital ’Burlo Garofolo’, Via dell’Istria, 65/1,
1-34137 Trieste, Italy
The study was carried out on 17 mildly atopic asthmatics
(mean age 14 + 5.3 years; FEV pred. 87-108%) performing
sport for more than 3 years and for at least 6 months each
year. Ten patients were swimmers and seven footballers.
Clinical data and details of drug use were compared at the
beginning and at the end of the observation period (at the
An assessment of bronchial hyper-reactivity in
children with atopic rhinitis
s. La Grutta, G. Cuttitta, F. Cibella, G. Panasci and
S. Spedale
Department of Paediatrics, Ospedale ’G. di Cristina’,
Piazza Montalto, 4-90134, Palermo, Italy; 2Istituto di
Scienza e Tecnologia dello Sport e dell’Attivitt Fisica,
and 3Istituto di Fisiopatologia Respiratoria, C.N.R.,
Palermo, Italy
Aspecific bronchial hyper-reactivity is frequently found in
atopic children. This study involved 41 children affected by
atopic rhinitis with normal pulmonary function and with-
out any symptoms relevant to bronchial asthma in their
personal histories. All the subjects were submitted to the
methacholine bronchial provocation test for the evaluation
of bronchial hyper-reactivity (BHR). Twenty-three subjects
(56%) demonstrated a mean methacholine dose, producing
a 20% FEV reduction (PD20) of 792 mcg ( + 535 SD) and
were labelled responders (R), while the remaining 18 were
non-responders (NR). A significant difference was found
between R and NR as regards the age of atopic symptom
onset (p 0.037). A close positive linear relationship be-
tween PD,. and subject age was found (p 0.0099). Four-
teen of the 23 R were admitted to an 8-week treatment
with inhaled nedocromil sodium (NS) 4 mg, 4 times a day.
At the end of the treatment, a second bronchial challenge
was performed: the PD20 appeared to be significantly
reduced (45%,p 0.034). It is concluded that children with
atopic rhinitis demonstrate a high prevalence of BHR.
Nedocromil sodium, because of its effectiveness, has to be
evaluated as first choice therapy in the treatment of BHR
in absence of airway obstruction.
Preventive effect of nedocromil sodium versus
sodium cromoglycate on exercise-induced
bronchoconstriction in children
C. Caffarelli, G. Cavagni, I. Stapane and C. Rossi
lClinica Pediatrica, Universitt di Parma, Via Gramsci, 14,
43100 Parma, Italy; XClinica Pediatrica, Universitt di
Brescia, Brescia, Italy
A comparison was made between the protective effects of
nedocromil sodium (NS) and sodium cromoglycate (SCG)
on exercise-induced asthma (EIA), in a double-blind cross-
over study in asthmatic children. Patients performed 6 min
of exercise without any treatment. Then, the same patients
SSO Mediators of Inflammation. Vol 3 (Supplement). 1994performed 6 min of exercise 20 min after administration of
4 mg of NS and 20 mg of SCG. Differences between
spirometric values (maximum percentage PEF fall and
FEV fall at 15 min) were not statistically significant for
comparisons between the two active treatments.
Nedocromil sodium was found to be as effective as SCG in
preventing EIA.
Effectiveness of nedocromil sodium in
preventing exercise-induced asthma in
children
M. Verini, A. Verrotti, M. P. Del Duca and G. Morgese
Department of Pediatrics, University of Chieti, Ospedale
Pediatrico, Via Nicolini 11, 66100 Chieti, Italy
Exercise-induced asthma is a well-known phenomenon,
which particularly affects children and which has an impor-
tant social impact. In order to assess the usefulness of
nedocromil sodium in the prevention of exercise-induced
asthma, 49 (15 female, 34 male) children who suffered
from asthma were studied; their mean + SD age was 9.2 +
3.0 (range: 3.3-19.1) years. On the first day, respiratory
function was evaluated by spirometry, basally and after a
6 min run. The inhalation of nedocromil sodium had a
great influence on post-exercise lung function measure-
ments; in fact, on the day of nedocromil sodium
pretreatment, our patients showed an increase of respira-
tory function which was sighificantly different from the
parameters recorded during, the first day. Our findings
suggest that nedocromil sodium is effective in the preven-
tion of exercise-induced asthma in paediatric age.
Problems of lung inflammation in cystic
fibrosis
G. Cazzola
Cystic Fibrosis Center, Verona, Italy
The progressive pulmonary disease found in cystic fibrosis
(CF) which is associated with Pseudomonas aeruginosa
Abstracts
infection has been related to the chronic severe inflamma-
tory host response. Thus, therapy that reduce pulmonary
inflammation may prove to have clinical efficacy. A wide
variety of agents that may modulate this inflammatory
vicious circle are being investigated and promising results
are coming out. Furthermore, large controlled trials are still
necessary to confirm clinical efficacy .and to continue im-
provement in the clinical course of CF patients.
The long-term effects of nedocromil sodium
on bronchial responsiveness to methacholine
and respiratory symptoms in atopic asthmatic
children
M. Pifferi, M. Baldini, C. Bertelloni, S. Cecchetti,
G. Fruzza and G. Baldini
Lung Function Laboratory and Allergy Center, Paediatric
Clinic, University of Pisa, Via Roma 35, 56100 Pisa, Italy
A long-term study of the effect of nedocromil sodium (NS)
on lung function, bronchial responsiveness to
methacholine, respiratory symptoms, corticosteroid and/or
bronchodilator intake in 15 atopic asthmatic children is
described. The study was divided into a baseline period (8
weeks), a treatment period (16 weeks), and a wash-out
period (8 weeks). Two inhalations of NS (2 mg per actua-
tion) were administered three times daily by metered dose
pressurised aerosol. Values of FEV1 did not change Signifi-
cantly, but increased slightly after 8 and 16 weeks of
treatment with NS. Significant changes (p 0.001) in FEF
25-75 with regard to the pretreatment values were re-
corded at the end of the treatment period. PD20FEV1
increased significantly after 8 (p< 0.001) and 16 weeks
(p<0.001). Asthma symptoms, and corticosteroid or
bronchodilator intake, decreased significantly after 8 and
16 weeks of treatment. In conclusion, NS appears to be
both effective and safe in the long-term treatment of
asthma in children.
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